Veozah (fezolinetant) was approved in 2023 by the FDA to treat moderate to severe hot flashes. A similar drug, elinzanetant, ...

When the FDA approved fezolinetant for treating moderate to severe hot flashes in menopausal women, the news made headlines.

Another of the most common symptoms associated with this time is hot flashes, as "approximately 70% of women will experience them at some point during the menopause transition," says Rebecca ...

We researched and tested ten supplements to identify the best option for hot flashes and night sweats. In the following sections, we’ll share our top pick and provide a breakdown of the runners-up.

Hot flashes can be associated with all of the above and can bring additional unwanted symptoms of their own. "Some 8 in 10 women will experience hot flashes during menopause or the menopause ...

While research specifically tying running to hot flashes is slim, it doesn’t seem like a far jump to think that running may ...